The IDO Battle Gets Ugly Post author:Sam Post published:October 24, 2017 Post category:BioPharma Incyte has been at the forefront of the IDO race with its candidate epacadostat. Source: BioSpace You Might Also Like Why These 3 Drugmakers Could Buy Incyte April 11, 2017 VEXIM Acquired by Stryker in EUR 183M Deal October 24, 2017 Pharma Giant Merck & Co. Considering 600-Job IT Hub in Austin April 5, 2017
